GraphRepur

GraphRepur predicts candidate drugs for breast cancer by integrating drug network-based and drug signature-based analyses with a GraphSAGE-based graph neural network.


Key Features:

  • Method integration: Integrates drug network-based approaches and drug signature-based analyses to combine network relationships and drug-induced gene expression signatures.
  • Graph model: Implements a GraphSAGE-based graph neural network to learn representations from drug networks.
  • Differential expression: Uses differentially expressed genes associated with breast cancer as biological input signals.
  • Drug-exposure data: Incorporates drug-exposure gene expression data to capture drug-specific transcriptional signatures.
  • Drug-drug links: Utilizes drug-drug link information to represent topological relationships between drugs within the network.
  • Signature and topology fusion: Captures both biological signatures of drugs and their topological relationships within the network.
  • Performance: Demonstrated superior performance compared to previous state-of-the-art approaches and several classic machine learning methods.
  • Output: Produces ranked candidate drugs for breast cancer treatment based on integrated network and signature information.

Scientific Applications:

  • Drug repurposing for breast cancer: Predicts and ranks candidate existing drugs for potential therapeutic use in breast cancer.
  • Literature-supported candidate identification: Identifies high-ranked drugs that have been reported in the literature as having therapeutic relevance to breast cancer.
  • Support for therapy development: Provides prioritized candidate drugs to inform ongoing breast cancer therapy research and validation efforts.

Methodology:

Integration of drug network-based and drug signature-based analyses achieved through a GraphSAGE-based graph neural network that uses differentially expressed genes associated with breast cancer, drug-exposure gene expression data, and drug-drug link information to capture biological signatures and topological relationships.

Topics

Details

License:
MIT
Tool Type:
library
Programming Languages:
Python
Added:
9/20/2021
Last Updated:
11/24/2024

Operations

Publications

Cui C, Ding X, Wang D, Chen L, Xiao F, Xu T, Zheng M, Luo X, Jiang H, Chen K. Drug repurposing against breast cancer by integrating drug-exposure expression profiles and drug–drug links based on graph neural network. Bioinformatics. 2021;37(18):2930-2937. doi:10.1093/bioinformatics/btab191. PMID:33739367. PMCID:PMC8479657.

PMID: 33739367
PMCID: PMC8479657
Funding: - State Key Program of Basic Research of China: 2015CB910304 - Key New Drug Creation and Manufacturing Program: 2018ZX09711002-001-003 - Strategic Priority Research Program of the Chinese Academy of Sciences: XDA12020372 - Tencent AI Lab Rhino-Bird Focused Research Program: JR202002

Links